Our finding that adiponectin concentration-metabolic risk factor relationships differed by RA status suggests that the influence of adiponectin on metabolic cardiovascular risk factors as identified in non-RA subjects cannot be merely extrapolated to patients with RA. The gene discussed is ADIPOQ; the disease is rheumatoid arthritis.